Study Atlas
Study accountPrivacySaved locally

Surgery

Tumors of the stomach

Distinguish a mucosal polyp, an infiltrating carcinoma, a subepithelial tumor and a postgastrectomy complication.

Very High Yield45 min lesson estimate104 question families

Well covered in the main question banks · 90 main-bank entries · 109 linked PDF entries · 0 generated drills

Prerequisites and related lessons
  • Peptic ulcer disease

Curriculum reference · Official College Textbook – Digestive Disorders – Part 1, pp. 72–85. Lesson adapted from Upper GIT surgery.

Topic map

  • Polypshyperplastic, fundic gland, adenoma
  • Malignanciesadenocarcinoma, lymphoma, GIST
  • Work-upbiopsy, CT, selective EUS or laparoscopy
  • Postoperativeleaks, dumping and deficiencies
Stomach regions and routes of spread Outward arrows show typical metastatic pathways from a gastric primary.FundusBodyAntrumPylorusCardiaLymph nodesLiverPeritoneum / ovary
Stomach regions and routes of spreadOutward arrows show typical metastatic pathways from a gastric primary.

Anatomy and lesion types

The cardia adjoins the esophagus, the fundus domes upward, and the body narrows through the antrum to the pylorus. The left gastric artery [Surgery Dept Q1] supplies much of the lesser curvature with the right gastric. Gastroepiploic arteries serve the greater curvature and short gastrics the fundus. The pancreas [Surgery Dept Q2] lies behind the lesser sac in the gastric bed. Gastric veins ultimately join the portal system. Acetylcholine, gastrin and histamine stimulate secretion, while somatostatin inhibits acid production [Surgery Mid gastric Q27].

An adenoma often occurs in the antrum and can be sessile (broad-based) or pedunculated (stalked). Gastric adenomatous polyps have malignant potential [Surgery Dept Q4] and warrant complete assessment, including background mucosa. The department keys hyperplastic polyp [Surgery Dept Q3] among its options. Actual prevalence depends on population and whether fundic gland polyps are counted. Hyperplastic polyps often accompany chronic mucosal injury, while fundic gland polyps are usually in body/fundus and can be associated with PPIs or polyposis. Leiomyoma, fibroma and lipoma may bleed.

Adenocarcinoma [Surgery Mid Q7/Q21 · Old p. 59] is the major epithelial malignancy. GIST is a mesenchymal neoplasm related to the gut's pacemaker cells (interstitial cells of Cajal), commonly KIT/CD117 and DOG1 positive. It can bleed and spread to liver or peritoneum. Resect localized tumors with an intact capsule and clear margins when feasible. Mutation and recurrence risk guide imatinib use. Gastric lymphoma includes H. pylori-associated MALT lymphoma (mucosa-associated lymphoid tissue) and diffuse large B-cell lymphoma. Selected localized H. pylori-associated MALT cases can regress after eradication, with histologic follow-up.

Risk and pathology

Book I lists smoked or salted food, tobacco, alcohol, Japan, family history and blood group A [Surgery Mid Q16 · Old p. 6]. H. pylori can lead through atrophic gastritis [Surgery Mid Q2/Q17 · Old], intestinal metaplasia and dysplasia to cancer. The exam 3 As are atrophy, achlorhydria [Surgery Mid Q2/Q17 · Old] and adenoma. The 3 Ps are pernicious anemia, chronic gastric peptic ulcer and prior gastric surgery. A suspicious ulcer can represent an existing malignancy, so obtain tissue. Achalasia and post-colectomy are course exceptions. Hereditary diffuse gastric cancer can involve CDH1, encoding a cell-adhesion protein.

Book I gives pylorus 65% [Surgery Mid Q9 · Old pp. 66, 96], body 25%, fundus 5% and diffuse 5% as course figures. Location varies across populations. Lauren intestinal type is gland-forming, frequently develops on metaplasia and can be fungating or ulcerative [Surgery Mid Q11 · Old p. 69]. Diffuse type comprises poorly cohesive cells, sometimes signet-ring cells with mucin that displaces the nucleus. Scarring and widespread wall infiltration create a rigid leather-bottle stomach (linitis plastica) [Book I pp. 73–75]. Book I also describes glandular, spheroid and colloid/mucinous microscopic patterns. Esophageal SCC can extend into the cardia.

Spread, symptoms and complications

Direct spread may extend 5 cm beyond the palpable edge [Surgery Mid Q4 · Old p. 60] in the textbook and involve liver, pancreas, transverse colon, spleen or diaphragm. Lymphatic spread [Surgery Mid Q15 · Old p. 6] is the classic commonest route and can involve perigastric and celiac-region nodes. Blood spread commonly reaches liver and less often lung or bone. Serosal breach enables peritoneal deposits, malignant ascites and Krukenberg tumor [Surgery Mid Q1 · Old p. 61], characteristic ovarian metastasis, classically gastric. Pelvic implants can form a rectal shelf.

Malignant dyspepsia [Surgery Mid Q5/Q20 · Old pp. 40, 60] includes new continuous discomfort, little relation to meals, spontaneous vomiting, anorexia and the classic loss of appetite for meat [Surgery Mid Q5 · Old p. 60]. Insidious 3 As are anemia, anorexia and asthenia (weakness). Cardia obstruction can produce dysphagia and pyloric obstruction or intractable vomiting [Surgery Mid Q1/Q14 · Old pp. 72, 83] can reflect local disease. Bleeding, acute perforation, wasting and distant spread may be the first presentation.

Distant clues include Virchow’s left supraclavicular node (Troisier sign) [Surgery Mid Q1 · Old p. 115], Sister Mary Joseph umbilical nodule [Surgery Mid Q14 · Old p. 72], malignant ascites, liver metastases with hepatomegaly/jaundice, Trousseau migratory thrombophlebitis and ovarian metastases.

Investigations

Initial assessment
Upper endoscopy for concerning gastric symptoms or lesions
Confirmation or staging
Biopsy proves the lesion. EUS assesses depth and CT assesses spread.

Gastroscopy with biopsies [Surgery Mid Q3/Q18/Q19 · Old] confirms diagnosis. The course describes four-quadrant sampling and contrast patterns: irregular fill defect (fungating), Carman meniscus and interrupted rugae (ulcerative) or a rigid narrow stomach (diffuse). Barium cannot provide tissue. Plain X-ray is unnecessary for routine elective cancer staging, but can assess an acute complication. Consider deeper or repeat sampling for infiltrative disease despite negative superficial biopsies.

CT [Surgery Mid Q8 · Old p. 86] assesses distant spread and resectability. EUS [Surgery Mid Q12 · Old p. 71] estimates local wall depth and adjacent nodes. Selective staging laparoscopy and peritoneal washings detect occult peritoneal disease. CEA is nonspecific and cannot substitute for biopsy or imaging. CBC, biochemical profile and nutritional assessment help prepare for therapy.

Management

Early low-risk lesions can qualify for endoscopic resection. Curative treatment uses margin-negative resection with suitable nodal clearance and perioperative treatment when appropriate. Localized advanced cancers commonly require systemic therapy as part of multimodality care. Advanced disease may be tested for HER2, PD-L1, MSI/MMR and CLDN18.2 to guide therapy. Stents, bypass, radiation or supportive care may relieve advanced bleeding or obstruction.

The course groups distal/antral disease under radical subtotal gastrectomy (historically about 85%, Billroth II gastrojejunostomy), body/diffuse disease under radical total gastrectomy [Surgery Mid Q6 · Old p. 61] with Roux-en-Y esophagojejunostomy or historical loop/interposition, and cardia/fundus under esophagogastrectomy. Its proximal cut is 3 inches beyond the palpable edge [Surgery Mid Q13 · Old p. 72], distal cut beyond the prepyloric vein of Mayo. Historical R1/R2/R3 names increasing resection of nodal tiers (perigastric, celiac-branch and more distant). In contemporary practice R0/R1/R2 denotes residual disease and D1/D2 nodal extent. Routine spleen and pancreas removal solely for clearance is no longer standard. Historical palliation examples include exclusion gastrojejunostomy and selected palliative resection.

Postgastrectomy complications

Early events include chest infection/atelectasis, anastomotic or duodenal stump leak and peritonitis, suture-line bleeding, ileus/internal hernia, pancreatic fistula and kinking. Late events include nutritional weight loss, iron deficiency, vitamin B12 deficiency with macrocytic anemia [Formative Q4] from loss of intrinsic factor, marginal ulcer, bile reflux gastritis, gastrojejunocolic fistula, afferent loop syndrome and dumping.

Early dumping [Dept Q5 · Formative Q3 · Old pp. 64, 67] occurs soon after meals. Rapid delivery of concentrated food draws water into the intestine and gut hormone release contributes to cramps, nausea, diarrhea, sweating, palpitations and dizziness. Late dumping [Old pp. 64, 80] develops about 1–3 hours after a meal from an excessive insulin response and reactive hypoglycemia. Small frequent meals and fewer rapidly absorbed carbohydrates are first measures. Postoperative planning includes B12 and iron monitoring/replacement.

Afferent loop syndrome [Old pp. 17, 84, 91] is obstruction of the limb carrying bile and pancreatic secretions to a Billroth II-type anastomosis. Intermittent obstruction can cause postprandial fullness and pain followed by a relieving gush of bilious vomiting. Complete obstruction can be acute without that relief. Roux-en-Y revision is one treatment option depending on cause. Bile reflux gastritis and marginal ulcer can cause pain and need endoscopic assessment. Gastrojejunocolic fistula can cause diarrhea, wasting and feculent belching or vomiting.

Exam traps

Biopsy proves cancer, EUS shows wall depth and CT evaluates distant disease. Pyloric obstruction can occur with a localized lesion. Troisier sign, malignant ascites, ovarian deposits and an umbilical nodule are metastatic clues. Meal timing and the mechanism distinguish early dumping from late dumping.

Diagnostic and management pathways

  • Alarm symptoms or suspicious lesionendoscopy with biopsies
  • Cancer provenCT and selective EUS or laparoscopystage and assess fitness
  • Early / resectable / metastaticendoscopic, multimodality or palliative treatment as appropriate
  • After resectionassess surgical complications, meal symptoms and deficiencies

Compare at a glance

EntityClueConfirmation or mechanism
AdenocarcinomaUlcerated or infiltrating lesion, weight lossGastroscopy with biopsy
Benign gastric ulcerCan mimic an ulcerated carcinomaSample suspicious gastric ulcer and assess healing as indicated
GISTSubepithelial lesion, bleedingEUS and tissue when indicated, KIT/DOG1, mutation testing
MALT lymphomaLymphoid proliferation, often H. pyloriBiopsy and lymphoma staging
Early vs late dumpingImmediate vasomotor symptoms vs delayed hypoglycemiaFluid shifts vs insulin overshoot

Supplementary clarification – not directly stated in the uploaded materials. Clinical references · NCI gastric cancer treatment · NCI GIST treatment

Exam words

  • left gastric artery [Surgery Dept Q1]
  • pancreas [Surgery Dept Q2]
  • somatostatin inhibits acid production [Surgery Mid gastric Q27]
  • Gastric adenomatous polyps have malignant potential [Surgery Dept Q4]
  • hyperplastic polyp [Surgery Dept Q3]
  • Adenocarcinoma [Surgery Mid Q7/Q21 · Old p. 59]
  • blood group A [Surgery Mid Q16 · Old p. 6]
  • atrophic gastritis [Surgery Mid Q2/Q17 · Old]
  • achlorhydria [Surgery Mid Q2/Q17 · Old]
  • pylorus 65% [Surgery Mid Q9 · Old pp. 66, 96]
  • fungating or ulcerative [Surgery Mid Q11 · Old p. 69]
  • leather-bottle stomach (linitis plastica) [Book I pp. 73–75]
  • 5 cm beyond the palpable edge [Surgery Mid Q4 · Old p. 60]
  • Lymphatic spread [Surgery Mid Q15 · Old p. 6]
  • Krukenberg tumor [Surgery Mid Q1 · Old p. 61]
  • Malignant dyspepsia [Surgery Mid Q5/Q20 · Old pp. 40, 60]
  • loss of appetite for meat [Surgery Mid Q5 · Old p. 60]
  • pyloric obstruction or intractable vomiting [Surgery Mid Q1/Q14 · Old pp. 72, 83]
  • Virchow’s left supraclavicular node (Troisier sign) [Surgery Mid Q1 · Old p. 115]
  • Sister Mary Joseph umbilical nodule [Surgery Mid Q14 · Old p. 72]
  • Gastroscopy with biopsies [Surgery Mid Q3/Q18/Q19 · Old]
  • CT [Surgery Mid Q8 · Old p. 86]
  • EUS [Surgery Mid Q12 · Old p. 71]
  • body/diffuse disease under radical total gastrectomy [Surgery Mid Q6 · Old p. 61]
  • 3 inches beyond the palpable edge [Surgery Mid Q13 · Old p. 72]
  • vitamin B12 deficiency with macrocytic anemia [Formative Q4]
  • Early dumping [Dept Q5 · Formative Q3 · Old pp. 64, 67]
  • Late dumping [Old pp. 64, 80]
  • Afferent loop syndrome [Old pp. 17, 84, 91]

Practice questions

Rapid revision sheet

Sixty-second recall. Say the definition, the key clue and the next clinical step out loud before checking the list.

  • left gastric artery [Surgery Dept Q1]
  • pancreas [Surgery Dept Q2]
  • somatostatin inhibits acid production [Surgery Mid gastric Q27]
  • Gastric adenomatous polyps have malignant potential [Surgery Dept Q4]
  • hyperplastic polyp [Surgery Dept Q3]
  • Adenocarcinoma [Surgery Mid Q7/Q21 · Old p. 59]

Official College Textbook – Digestive Disorders – Part 1, pp. 72–85

Active recall

A patient with gastric malignancy has a palpable left supraclavicular node. What does this finding represent?

A Virchow node. It indicates metastatic spread and should prompt full staging.

Official College Textbook – Digestive Disorders – Part 1, pp. 72–85

Recall the diagnostic and management pathway from memory.

Start with the presenting clue, name the first assessment, then distinguish confirmation, immediate management and follow-up.

  • Alarm symptoms or suspicious lesionendoscopy with biopsies
  • Cancer provenCT and selective EUS or laparoscopystage and assess fitness
  • Early / resectable / metastaticendoscopic, multimodality or palliative treatment as appropriate
  • After resectionassess surgical complications, meal symptoms and deficiencies
↑